By Eva Hofmann
It is official.
Governor JB Pritzker has signed the bill
legalizing recreational marijuana for adult use, beginning in January
2020. Marijuana for medical use under a doctor’s prescription already is
legal in Illinois.
This is the second in a three-part series of articles to help inform Gazette Chicago readers about the pros and cons of legal cannabis. Here, we focus on the drug’s health aspects.
Treating pain and disease
What are cannabinoids? The chemicals in marijuana are known as cannabinoids, and
the two main cannabinoids of medical interest are cannabidiol (CBD) and
tetrahyrocannabinol (THC). Unlike THC, CBD does not make people high.
Researchers continue to explore uses of THC, CBD, and other cannabinoids
for medical treatment.
Cancer. According to the American
Cancer Society, several small studies found smoked marijuana helped
treat nausea and vomiting from cancer chemotherapy. Other studies have
shown smoked or vaporized marijuana can help treat pain caused by
damaged nerves and improve food intake.
More recently, scientists reported THC
and other cannabinoids such as CBD slow growth or cause death in
certain types of cancer cells growing in lab dishes. Some animal studies
suggest certain cannabinoids may slow growth and reduce the spread of
some forms of cancer.
Researchers have conducted some early clinical trials of cannabinoids in treating cancer in humans, with more planned.
Alzheimer’s. While THC is said to
slow Alzheimer’s disease’s progression, the Alzheimer’s Association
states more research is needed. “Marijuana, like many supplements and
alternative treatments, is not regulated, so we can’t guarantee its
purity or safety,” said Rebecca Edelmayer, PhD, the association’s
director of scientific engagement. “It has not undergone testing,
review, or scientific scrutiny, so we do not have enough rigorous trial
data to predict a benefit.
“We also don’t know if marijuana
interacts with medically approved prescriptions, so we are approaching
the issue with caution until research is done,” Edelmayer added. The
Alzheimer’s Association has sponsored research in this area, “but
without scientific data to back up efficacy, we cannot take a position
to advocate for its use,” she said, adding that people can take other
steps to prevent and treat Alzheimer’s.
“We’ve seen research suggesting that
incorporating multi-component changes into your daily habits could
decrease your risk,” she said. The Alzheimer’s Association advocates
lifestyle choices—including healthful diet, exercise, and cognitive and
social stimulation—to help decrease risk of cognitive decline and
dementia.
Glaucoma. Marijuana reduces
pressure inside the eye caused by glaucoma, which can injure the optic
nerve and cause loss of vision. According to the Glaucoma Research
Foundation, however, marijuana’s effect on eye pressure lasts only three
to four hours, meaning someone would have to smoke six to eight times
throughout the day to lower eye pressure around the clock. Researchers
have investigated using eye drops containing THC or related compounds
but have not been able to formulate an eye drop that can introduce the
drug into the eye in concentrations high enough to be effective.
Pain relief. A growing body of
research and anecdotal evidence suggests marijuana or its compounds may
help relieve some types of pain. While marijuana lacks enough strength
to ease severe pain, it is quite effective for chronic pain. Safer than
opiates, it can take the place of pain relievers such as Advil and Aleve
if people cannot take them due to gastrointestinal or kidney problems.
An online survey featured in the Journal of Alternative and Complementary Medicine showed
marijuana could promote sleep and reduce pain and inflammation, which
can help relieve symptoms for people with rheumatoid arthritis. In the
study, researchers found Sativex, a cannabinoid-based pain medicine,
helped patients feel less pain and sleep better just two weeks after
taking the drug.
Epilepsy. According to the
Epilepsy Foundation, scientists have studied marijuana’s role in
treating epilepsy and other neurological conditions for a number of
years. In 2018, the FDA approved a drug, Epidolex, to treat seizures
associated with two epilepsy syndromes—Lennox-Gastaut syndrome and
Dravet syndrome—in people age two or older.
Concern over adolescent use
While the new law stipulates legal
marijuana use for adults age 21 and older, some worry legalization will
make it easier for teens and young adults to access the drug.
Adolescent marijuana use may alter neuron
function in brain areas engaged in decision making, planning, and
self-control, according to researchers at the University of Illinois at
Chicago (UIC).
“Substance use as a teenager has the potential to disrupt the normal developmental trajectory of the prefrontal cortex, with potentially long-term consequences for decision making,” said Jamie Roitman, UIC associate professor of psychology and study co-author.
“Substance use as a teenager has the potential to disrupt the normal developmental trajectory of the prefrontal cortex, with potentially long-term consequences for decision making,” said Jamie Roitman, UIC associate professor of psychology and study co-author.
Physician and Bridgeport resident Irene
O’Neill, MD, also has concerns. “Marijuana is a gateway drug, especially
with the strength of the marijuana being used today,” she said.
O’Neill said the dangers of using
marijuana increase greatly in people younger than 25, as their brains
have not reached full development. “The less developed the brain, the
higher the risk of addiction,” said O’Neill.
According to the National Institute on
Drug Abuse (NIDA), people who begin using marijuana before age 18 are
four to seven times more likely to develop a marijuana use disorder. This
demographic faces a higher risk of addiction and moving on to other
drugs as well as greater risk of psychosis, schizophrenia, depression,
anxiety, and other psychiatric problems.
Baby boomers are at it again
The 2016 National Survey of Drug Use and
Health showed a ten-fold increase in cannabis use among adults beyond
age 65. Some older users reported positive outcomes when using cannabis
for pain as opposed to taking prescription opioids.
A Colorado study published in the May 2019 issue of Drugs and Aging showed cannabis use among older adults is growing faster than for any other age group.
“Older Americans are using cannabis for a lot of different reasons,”
said Hillary Lum, MD, PhD, assistant professor of medicine at the
University of Colorado School of Medicine, who co-authored the paper.
“Some use it to manage pain while others use it for depression or
anxiety.”
Researchers found some felt reluctant to
ask their doctors for a medical marijuana card. Instead, they chose to
pay more for recreational cannabis. Lum said this behavior could stem
from self consciousness about asking a doctor for cannabis.
“From a physician’s standpoint, this
study shows the need to talk to patients in a non-judgmental way about
cannabis,” said Lum. “Doctors should also educate themselves about the
risks and benefits of cannabis and be able to communicate that
effectively to patients.”
Is marijuana addictive?
According to NIDA, cannabis can lead to
marijuana use disorder, in which a person feels withdrawal symptoms when
not taking the drug. People who use marijuana frequently report
irritability, mood and sleep difficulties, decreased appetite, cravings,
restlessness, and various forms of physical discomfort that peak within
the first week after quitting and last up to two weeks.
It is possible to be dependent without
being addicted. Marijuana use disorder becomes addiction when the person
cannot stop using even when it interferes with aspects of daily life.
Studies suggest 9% of people who use marijuana will become dependent on
it. That number rises to about 17% in those who start using in their
teens.
Regulated cannabis is better
The good news is that legalization leads
to better cannabis products, according to Jonathan Loiterman, an
Illinois attorney and cannabis entrepreneur at Green Star Growing.
“People have been buying marijuana on the black market for decades,” he
said, citing possible contaminants in unregulated, black-market cannabis
products, which could include mold, heavy metals, and pesticides.
“Legal cannabis will be safer because it’s being tested,” said
Loiterman. “We can debate about whether cannabis is good for pain.
Legalization gets that research to happen.”
For the Alzheimer’s Association, log on
to www.alz.org. For the Epilepsy Foundation, see www.epilepsy.com. Log
on to www.glaucoma.org for the Glaucoma Research Foundation. For Green
Star Growing, log on to www.greenstargrowing.com. For Lum, call (720)
848-3400, and for Roitman email jroitman@uic.edu. Log on to
www.drugabuse.gov for the National Institute on Drug Abuse.
Editor’s note: This is
the second in a Gazette Chicago three-part series of articles on the
advantages and disadvantages of legalized cannabis in Illinois. The
third installment in the series will focus on public health and safety
related to cannabis legalization.
No comments:
Post a Comment